Rainbow Childrens Medicare Ltd

Q1 FY27Healthcare Services

Rainbow Childrens Medicare Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹1,445

Market cap₹14.6K Cr

P/E50.8

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

2 of 3 strong

RevenueRank 2

MarginRank 3

CapexYes

Not discussed on this call: fundraise, order book.

The short version

Revenue growth target is around 20% annually, aiming to double revenue over approximately 4 years (Page 15). Rainbow Children's Medicare Limited targets ~20% annual revenue growth over the medium term, aiming to double revenues in approximately four years.

From Rainbow Childrens Medicare Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 2

Revenue growth target is around 20% annually, aiming to double revenue over approximately 4 years (Page 15).
Current trajectory expects revenue to cross INR 2,000 crores by the end of the financial year and double in the next four years (Page 10).
Volume growth supported by planned addition of 2,500 beds over 5 years (~15% CAGR) (Page 10).
New Bengaluru hospitals expected to breakeven within 12-15 months, all within about 18 months (Page 20).
Acquisitions in Andhra Pradesh (Nellore, Guntur) expected to stabilize in 6 months and contribute positively to cluster performance by year-end (Page 20).
Expansion into new markets like Mumbai, Delhi NCR, Northeast, and Central India anticipated to drive incremental growth (Pages 13, 15).
Digital initiatives and stronger doctor engagement aimed at sustaining and accelerating revenue growth above 20% going forward (Pages 16, 18).

Profitability & Margins

Rainbow Children's Medicare Limited targets ~20% annual revenue growth over the medium term, aiming to double revenues in approximately four years.
EBITDA margins are expected to improve as new hospitals mature, with a long-term margin target of 24-25% (pre-Ind AS basis) by year-end.
Newly acquired hospitals like Guwahati and Warangal are EBITDA positive; newer greenfield hospitals are approaching breakeven within 12-18 months.
Profit after tax grew 16% YoY in Q1 FY27, with ongoing margin expansion expected as operational leverage improves.
Expansion into new markets (Delhi NCR, Mumbai, Central India) and higher-value tertiary/quaternary pediatric services will drive ARPOB growth and profitability.
Digital and operational efficiency initiatives are expected to further enhance earnings quality and growth sustainability.
Overall, the company expects sustained long-term growth and increasing profitability as capacity and market presence expand.

See what Rainbow Childrens Medicare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Invested approximately INR 56 crores towards capital expenditure during the quarter, primarily focused on expanding and strengthening capabilities across existing hospitals and upcoming projects.
Planning to add around 2,500 beds over the next five years as part of capacity expansion.
Ongoing capital expenditure program funded through strong internal accruals and a robust balance sheet with cash and investments totaling INR 613 crores as of June 30, 2026.
Exploring and executing acquisitions and greenfield projects in new markets including Mumbai, Noida, Central India, Bhubaneswar, and Raipur to broaden presence.
Focus on building hub-and-spoke networks for operational efficiency and clinical strength.
Investment in technology and digital initiatives, including a new CRM platform, lead management system, and modernization of Hospital Information Systems.
Continuous project execution and capital cost management remain top priorities to support growth trajectory.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹981 Cr

Rev 1Mar 1

2CHANDAN₹518 Cr

Rev 1Mar 3

3₹66.5K Cr

Rev 2Mar 1

4₹654 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Rainbow Children's Medicare Limited maintains a strong balance sheet with cash, cash equivalents, and investments totaling INR 613 crores as of June 30, 2026.
The company is a cash-surplus organization and funds its capital expenditure and expansion primarily through internal accruals.
There is no explicit mention of any current or planned fundraising through debt or equity in the presented excerpts.
The financial strategy emphasizes treasury management to balance liquidity, capital safety, and returns without relying on external fundraising.
Expansion and acquisitions are being financed through available cash resources, supporting seamless integration and ongoing growth.
Overall, the company appears well-capitalized and does not currently anticipate the need for additional debt or equity fundraising.

See what Rainbow Childrens Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Rainbow Children's Medicare Limited. However, related operational and growth insights include: - The company plans to add approximately 2,500 beds over the next 5 years, with around 1,200 beds already identified. - About 30% of bed additions will be in existing southern markets; 70% will be in newer markets like Delhi NCR, Mumbai, Central India. - Ongoing acquisition integration includes hospitals in Guwahati and Warangal, both EBITDA positive. - Greenfield projects include Rajahmundry and Electronic City (Bangalore), currently ramping up to breakeven. - Expansion in Mumbai and Delhi NCR is actively underway, with a focus on building regional leadership and clusters. - The company aims to double revenue over the next 4 years through sustained ~20% annual growth, supported by capacity additions and geographic expansion. No specific order book or pending orders figures are detailed in the provided pages.

Rainbow Childrens Medicare Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹460 Cr, net profit ₹78 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Rainbow Childrens Medicare Ltd's management said in earlier quarters

Others in Healthcare Services this season

Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
Fortis Healthcare Ltd (Q1 FY27)
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare Institute Ltd vs Manipal Health Enterprises Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Rainbow Childrens Medicare Ltd Q1 FY27 results?

What is Rainbow Childrens Medicare Ltd share price analysis?

Rainbow Childrens Medicare Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 50.8 with a market cap of ₹14,557 Cr. Investors should review the full earnings analysis for detailed insights.

Is Rainbow Childrens Medicare Ltd planning capital expenditure?

Invested approximately INR 56 crores towards capital expenditure during the quarter, primarily focused on expanding and strengthening capabilities across existing hospitals and upcoming projects.

Keep Rainbow Childrens Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.